Drug product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
D-0241-2026
Product summary
- Event
- Event 98113
- Status
- Ongoing
- Classification
- Class II
- Quantity
- 3 - single dose kits
- Official record key
drug-enforcement:D-0241-2026
Official wording
Reason: Presence of particulate matter: potential presence of metal particulates in the product.
Code information: Lot #: Z014503, Exp 11/15/2027
Distribution pattern: Nationwide in the USA
Derived failure modes
-
Foreign material or chemical contamination
particulate matter